Duchenne and Becker muscular dystrophy are X-linked neuromuscular disorders characterized by progressive muscle degeneration. Despite the involvement of multiple systems, secondary conditions among affected males have not been comprehensively described. Two hundred nine caregivers of affected males (aged 3-31 years) identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network completed a mailed survey that included questions about secondary conditions impacting multiple body functions. The 5 most commonly reported conditions in males with Duchenne were cognitive deficits (38.4%), constipation (31.7%), anxiety (29.3%), depression (27.4%), and obesity (19.5%). Higher frequencies of anxiety, depression, and kidney stones were found among nonambulatory males compared to ambulatory males. Attention-deficit hyperactivity disorder (ADHD) was more common in ambulatory than nonambulatory males. These data support clinical care recommendations for monitoring of patients with Duchenne or Becker muscular dystrophy by a multidisciplinary team to prevent and treat conditions that may be secondary to the diagnosis.
Duchenne and Becker muscular dystrophies are the most common pediatric inherited muscular dystrophies. 1, 2 The most prominent feature is progressive muscle degeneration that leads to loss of ambulation, as well as primary multisystem complications involving the heart, skeletal, and respiratory systems. 3 Multidisciplinary care is recommended for clinical management of Duchenne and Becker muscular dystrophies, and such care typically includes monitoring and treatment of complications, including oral corticosteroids to maintain muscle strength. [3] [4] [5] Though focus on primary complications is important for diagnosis and clinical management of Duchenne and Becker muscular dystrophies, secondary complications may also develop and amplify the severity of disease. 4, 5 These complications, commonly referred to as secondary conditions, include additional physical or mental problems that are related to the underlying disease. 6 Previous studies have typically focused on a single or few conditions that could be considered secondary to a diagnosis of Duchenne muscular dystrophy. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Collectively, these studies suggest a higher than expected occurrence of conditions affecting cognition, behavior, gastrointestinal, and genitourinary functioning.
In this study, we surveyed caregivers of males with Duchenne or Becker muscular dystrophies identified through the population-based Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) about the presence of secondary conditions affecting multiple body systems. The objectives of this study are to report the frequencies of a broader range of secondary conditions than previously reported by phenotype of Duchenne or Becker muscular dystrophy and to evaluate whether frequencies of these conditions differ by ambulation status.
Methods
MD STARnet is a population-based surveillance system established in 2002 by the Centers for Disease Control and Prevention to determine the prevalence of Duchenne and Becker muscular dystrophies and track clinical practices and health outcomes. 26 Beginning in 2004, MD STARnet retrospectively identified and longitudinally followed individuals who were born since January 1, 1982, diagnosed by December 31, 2011, and resided in 4 US sites: Arizona, Colorado, Iowa, and western New York State. In 2005 and 2008, Georgia and Hawaii, respectively, joined the network. MD STARnet used medical record data and pertinent state (eg, state vital records, hospital discharge, and emergency room visits) and national data (eg, national death index) to describe the care and outcomes of these individuals. Annual follow-up abstraction was attempted for at least 1 year for ascertained individuals. Individuals identified before September 2011 were followed through December 2011, and those identified between September 2011 and December 2011 were followed through December 2012. A committee of clinical experts reviewed clinical and laboratory data to assign each individual a case definition designation (definite, probable, possible, asymptomatic, affected female, or not Duchenne or Becker muscular dystrophy). The data used for assigning the case definition included clinical symptoms, age at onset of symptoms, diagnostic testing (ie, creatine kinase value, DMD mutation analysis, muscle biopsy results, and family history). 24 Full descriptions of MD STARnet surveillance methods and case definitions have been published previously.
26,27

Survey Collection
The Family Quality of Life Survey was developed by MD STARnet investigators and inquired about issues such as family quality of life, social support and stress, spirituality, and the affected male's current functioning and secondary conditions. The questions were primarily multiple-choice style responses, but some write-in responses were included. The survey asked caregivers to report if their child's doctor or health care provider ever informed them that their child had/has each of 29 conditions. The timing of these conditions included any time up to the point of survey completion. Investigators modeled questions about lower extremity function after the Vignos Lower Extremity Scale in which the caregiver chooses the option that best describes their child's level of lower extremity physical functioning. 28 Responses about the affected male's secondary conditions and lower extremity function, and caregiver and affected male demographics (eg, date of birth, date of survey completion), were used for this cross-sectional study.
Sample and Methods
Investigators identified eligible caregivers using MD STARnet surveillance data and recruited participants from 6 MD STARnet sites (Arizona, Colorado, Georgia, Hawaii, Iowa, and western New York State). Two participants from Hawaii were excluded from analyses because of an abbreviated recruitment protocol. Caregivers of living males with definite or probable Duchenne or Becker muscular dystrophy were eligible. The sample included 460 caregivers defined (in priority order) as birth mother, birth father, and legal guardian. Only 1 caregiver was selected per household and, among those with multiple affected children, the caregiver was asked to complete the survey for the oldest affected male in the household if still living (Figure 1) . If the oldest affected male was not living, the caregiver was asked to complete the survey for the next oldest sibling. For the majority of caregivers (n ¼ 457), the eligible child was the first-born affected male. Caregivers were excluded from recruitment if they refused further contact following previous recruitment, were not currently the primary caregiver (eg, individuals who did not have a designated primary caregiver or did not live with the caregiver), could not be located during prior recruitment efforts, or were identified after recruitment was initiated. Participants completed surveys between April 2011 and February 2012. The protocol and consent for the caregiver survey varied by site. Overall, eligible caregivers were invited to complete the survey and could refuse participation or opt out at any time. In most sites, consent was implied if the caregiver completed and returned the survey, but written consent was required in Colorado. The survey was available in English and Spanish and compensation was provided. Each site received institutional review board approval for the Family Quality of Life Survey.
Statistical Analyses
Two secondary conditions, developmental delay affecting learning and mental retardation/intellectual disability, were combined into 1 cognition category called cognitive deficits. Ambulation ceased was defined for survey participants using caregiver responses to the Vignos scale items and included males who could not walk with assistance, used a wheelchair, or were confined to bed. 28 Additional survey data incorporated in analyses included responses about date of survey completion and dates of birth for caregivers and affected males.
To evaluate differences between participants and nonparticipants, the survey data were supplemented with surveillance data about sociodemographics, ambulation status, and Duchenne or Becker muscular dystrophy phenotype. Sociodemographic information included MD STARnet site, affected male date of birth, race/ethnicity, caregiver relationship to the affected male, and neighborhood percentage below poverty. Neighborhood percentage poverty, defined as the percentage of residents in the census tract with household incomes below the federal poverty line, was calculated by combining residential information as of the most recent clinical visit with US census tract data from The Public Health Disparities Geocoding Project Monograph created by the Harvard School of Public Health. 29 Individual race/ ethnicity was determined from medical and vital records (nonHispanic white, Hispanic, non-Hispanic Black, Other, Unknown). Age of affected males was grouped into 4 categories (3-10, 11-15, 16-20, 21-31 years of age). Ambulation status (ie, ambulatory vs nonambulatory) was differentiated by whether an age for ambulation cessation was recorded in the surveillance data set. Affected males were categorized as having a Duchenne phenotype if any of the following criteria were met: (1) ambulation ceased before 12 years of age or 16 years of age, when prior to cessation, any steroid use or continuous steroid use of at least 24 months was ascertainable, respectively; (2) observation of an out-of-frame DMD mutation consistent with a Duchenne phenotype or a Western blot showing less than or equal to 5% dystrophin; or (3) onset of symptoms occurred before 5 years of age. Affected males were categorized as having a Becker phenotype if any of the following criteria were met: (1) ambulation ceased after 16 years of age, regardless of steroid use; (2) observation of an in-frame DMD mutation consistent with a Becker phenotype or a Western blot showing less than or equal to 20% dystrophin; or (3) onset of symptoms occurred after 10 years of age. Those individuals for whom a Duchenne or Becker phenotype could not be determined were assigned an Indeterminate phenotype.
Missing information was limited to at most 4 observations for all variables-with the exception of neighborhood percentage poverty (52 missing). We excluded individuals with missing observations, where appropriate. We included the 52 individuals with missing values for neighborhood percentage poverty as "unknown." For analyses describing the frequencies of secondary conditions, responses of caregivers about males assigned the Indeterminate phenotype were excluded (n ¼ 17). We used t tests to compare mean values for continuous variables and chi-square or Fisher exact tests to compare categorical variables. We conducted all statistical analyses using SAS version 9.3 (SAS Institute, Cary NC), and statistical significance was defined by a P value <.05.
Results
Participants
Of the 460 eligible caregivers, 209 completed the survey, 170 refused, and 81 could not be located (Figure 1 ). Males for whom the surveys were completed were aged 3 to 31 years. Using the American Association for Public Opinion Research rate calculator, 30 we estimated an overall response rate of 50.8%, a refusal rate of 28.7%, and a contact rate of 81.0%. Using the same calculator, we estimated the cooperation rate for each MD STARnet site: 75.3% for Arizona, 45.0% for Colorado, 53.8% for Georgia, 81.8% for Iowa, and 82.4% for western New York. Table 1 summarizes differences between participants and nonparticipants based on surveillance data through 2011. Most surveys (95.2%) were completed by biological parents, and 91.4% by females (data not shown). Participants were more likely to be caring for non-Hispanic white males (71.8%) than nonparticipants (57.0%). The majority (80.0%) of eligible caregivers did not live in a poverty area (ie, census tracts with poverty rates of 20 percent or more) (data not shown). For this reason, we stratified eligible participants by the median neighborhood percentage poverty value (7.5%). Participants were more likely to have a known neighborhood percentage poverty value and live in a geographical area where less than 7.5% of its residents had a household income below the federal poverty line than nonparticipants. Participant caregivers were more likely to be caring for older males compared to nonparticipants (data not shown). The mean age of males cared for by nonparticipants was 16 years while the mean age of males cared for by participants was 17 years (P ¼ .04). Participation by caregivers was not associated with phenotype or ambulation status of affected males.
Descriptive Analyses
Of the 209 males whose caregiver completed the survey, there were 164 with the Duchenne phenotype, 28 with the Becker phenotype, and 17 with an Indeterminate phenotype. Frequencies of secondary conditions in males with Duchenne or Becker phenotypes are listed in Table 2 . Responses of caregivers of affected males for whom a phenotype could not be determined were excluded. In this study, the 5 most commonly reported secondary conditions for males with the Duchenne phenotype were cognitive deficits (38.4%), anxiety problems (29.3%), depression (27.4%), constipation (31.7%), and obesity (19.5%) ( Table 2 ). Among males with the Becker phenotype, the most frequently reported conditions were cognitive deficits (35.7%), depression (28.6%), attention-deficit hyperactivity disorder (ADHD) (32.1%), constipation (21.4%), and trouble holding urine (21.4%). Table 3 shows associations between reported secondary conditions and ambulation status of affected males with the Duchenne phenotype. Caregivers of ambulatory males were likely to report attention-deficit hyperactivity disorder compared to those of nonambulatory males (P < .01). Conversely, caregivers of nonambulatory males were more likely to report anxiety (P ¼ .02), depression (P < .01), and kidney stones (P ¼ .02), compared to caregivers of ambulatory males. Although not statistically significant, a higher percentage of caregivers of nonambulatory males versus those of ambulatory males reported high blood pressure (P ¼ .07), whereas a higher percentage of caregivers of ambulatory males reported asthma compared to caregivers of nonambulatory males (P ¼ .06).
Bivariate Analyses
Discussion
In this population-based, cross-sectional study, we described the frequencies of a broad range of mental and physical conditions among individuals diagnosed with Duchenne or Becker muscular dystrophy and compared frequencies of these conditions by ambulation status among males with the Duchenne phenotype. Caregivers of males with Duchenne or Becker phenotypes reported secondary conditions affecting cognition, behavior, obesity, gastrointestinal, and genitourinary functioning. We did not formally compare differences in the frequencies of secondary conditions by phenotype due to small cell counts among those with the Becker phenotype. Significant differences in frequencies of selected conditions were found by ambulation status for males with the Duchenne phenotype with higher frequencies for anxiety, depression, and kidney stones among nonambulatory males, and a higher frequency of attention-deficit hyperactivity disorder among ambulatory males. Males with Duchenne muscular dystrophy are frequently reported to have an average IQ below that of the general population. 7, 12, [17] [18] [19] [20] [31] [32] [33] [34] In this study, caregivers were asked to report if their child had been diagnosed with cognitive issues that included developmental delay affecting learning and mental retardation/intellectual disability. Among those with the Duchenne phenotype, 38.4% of caregivers reported at least 1 of the 2 cognitive issues. When considering the full spectrum of cognitive issues, our estimate falls within the range of studies reporting on cognitive function among males with Duchenne muscular dystrophy. 7, 12, [17] [18] [19] [20] 31, 32 Several studies have also focused on behavior problems among males with Duchenne muscular dystrophy. In this study, the percentage of caregivers reporting attention deficit hyperactivity disorder (14.0%), obsessive compulsive disorder (11.0%), or autism spectrum disorder (6.7%) was slightly higher than that reported (11.7%, 4.8%, and 3.1%, respectively) by caregivers in a larger study by Hendriksen et al (n ¼ 351). 21 Similar to this study, Caspers Conway et al 11 found attention deficit hyperactivity disorder in 18.0% of affected males in MD STARnet using medical record abstraction data (n ¼ 765). In this study, the percentage of males with caregiver-reported depression (27.4%) and behavioral/conduct issues (12.2%) differed from those found by Caspers Conway et al, 11 which had lower rates of depression (17.0%) but higher rates of behavior problems (26.0%). The observed differences are likely a result of data collection methods, attributes of the study population including average age, and condition definitions. Of note, the aforementioned behavior problems were more prevalent in this study population than that reported for general pediatric and adolescent populations. [35] [36] [37] [38] [39] [40] Small clinic-based studies have identified co-occurrence of gastrointestinal and nutritional issues in the Duchenne population. 10, 22, 41 It has been suggested that some of these problems may be related to reduced gastric motility.
7,10 A clinic-based study of 118 patients with Duchenne muscular dystrophy by Pane et al 10 described percentages of their patients with weight above 2 standard deviations (3.4%), gastroesophageal reflux needing treatment (4.2%), and constipation needing treatment (36.4%). In the current report, the gastrointestinal and nutritional issues reported most often by caregivers were obesity (19.5%), gastroesophageal reflux/ heartburn (17.7%), and constipation (31.7%). Jaffe et al 22 reported a similar percentage of heartburn (16.3%) to our study in their 55 patients with Duchenne muscular dystrophy. The frequency of constipation is slightly higher than that of the general pediatric population. 42, 43 However, it is difficult to compare data across studies because clinical definitions may vary. [42] [43] [44] [45] [46] In this study, higher frequencies of anxiety, depression, and kidney stones were found among nonambulatory males when compared to ambulatory males with the Duchenne phenotype. The findings of higher frequencies of anxiety and depression among those who are no longer able to independently ambulate may be due to increased disease awareness facilitated by agerelated cognitive development or by emergent symptoms of muscle weakness and wasting as disease progresses. 47 The finding of a higher frequency of kidney stones in nonambulatory males with Duchenne muscular dystrophy is consistent with findings from a study that used MD STARnet surveillance data as well as other clinic-based studies. 14, [23] [24] [25] A higher frequency of attention-deficit hyperactivity disorder was reported for ambulatory males compared to nonambulatory males with the Duchenne phenotype. These findings contradict the statistically nonsignificant association with ambulation status found by Caspers Conway et al, 11 which used 12 Thus, one potential confounding factor to the observed difference in this paper may be recall bias due to the age of the affected male at survey completion. Attention-deficit hyperactivity disorder is a childhood disorder, and Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition diagnostic criteria require onset before the age of 7 years. Less time from diagnosis to survey completion may have contributed to better recall of the diagnosis among caregivers of younger, ambulatory children compared with caregivers of older, nonambulatory males.
Limitations of this study include generalizability of study results to the larger patient population, which is common of observational studies that rely on subject report. In this study, participants were more likely than nonparticipants to be nonHispanic White and live in census tracts with less than median percentage poverty. In addition, the survey was cross-sectional and did not collect the date when a secondary condition was first diagnosed, which prohibited analyses of factors where time ordering was clinically important (eg, corticosteroid use preceding onset of behavior problems) Because of the variability in age of the individuals at the time of survey recruitment, caregiver reports may be influenced by recall bias depending on the time elapsed between a secondary condition diagnosis and survey participation. Results are also based on caregiver report, which could result in under-or over-reporting of secondary conditions. The small sample size of some conditions introduced statistical uncertainty and limited the power of certain conclusions. Finally, this study used available clinical data abstracted from medical records to determine Duchenne or Becker phenotypes. This resulted in 17 cases being assigned an Indeterminate phenotype and exclusion from analyses, further reducing our sample size.
Conclusion
According to caregiver reports, males with Duchenne or Becker phenotypes were reported to have lifetime diagnoses of conditions affecting cognition, behavior, gastrointestinal, and genitourinary functioning. These data support clinical care recommendations for careful monitoring of patients with Duchenne or Becker muscular dystrophy by a multidisciplinary care team to identify conditions that may be secondary to the diagnosis. Longitudinal follow-up of disease progression and the emergence of these conditions would help identify potential etiology and aid in their prevention and/or treatment.
